Inside Precision Medicine January 21, 2025
Helen Albert

A fast test to determine if an infection is viral or bacterial or whether a patient may progress to a more severe condition such as sepsis, has been approved by the FDA.

The test was developed by California-based Inflammatix. Known as TriVerity, it is a benchtop machine that uses a cartridge-based system to test patient samples.

It is able to measure the expression of 29 genes that regulate a person’s response to infection and assess if they have a high likelihood of having a bacterial or viral infection within around 30 minutes.

The test is also able to indicate how sick a patient is likely to become over the week following the test. For example, if they have a condition...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: FDA, Govt Agencies, Provider
How AI is changing cancer treatment
6 tips for starting an RPM program
Baptist Health breaks ground on medical office building, ASC
Improving the patient experience can pay dividends you may not expect
Ohio hospital files for bankruptcy

Share This Article